The Goldilocks Principle: Optimal Antithrombotic Strategies in the Cardiac ICU

Posted on May 23, 2023
Dr. DiDomenico, Shega, and Wieruszewski

Speakers:
Robert J. DiDomenico, PharmD, FCCP, FHFSA, FACC
Associate Professor
Assistant Head, Faculty Affairs & Strategic Initiatives, Department of Pharmacy Practice Clinical Pharmacist, UI Health

and

Alissa Shega, PharmD, BCCP
Clinical Pharmacist, Cardiac Intensive Care Unit
Rush University Medical Center

and

Patrick M. Wieruszewski, PharmD, BCCCP
Assistant Professor of Anesthesiology
Assistant Professor of Pharmacy
Cardiothoracic Surgery & ECMO Program
Mayo Clinic

A Knowledge-Based Activity
ACPE UAN # 0016-0000-23-031-L01-P, 1.0 contact hour, 1.0 AMA PRA Category 1 Credit(s)™ CME, 1.0 contact hour CNE

Learning Objectives:

  • Review the pharmacology of bivalirudin and alternative parenteral anticoagulants used to treat acute coronary syndrome (ACS).
  • Review the safety and efficacy of bivalirudin and other parenteral anticoagulants for the treatment of ACS.
  • Discuss updates in the management of purge solution for patients receiving Impella® support.
  • Discuss pharmacologic strategies for maintenance anticoagulation during extracorporeal membrane oxygenation (ECMO).

Speaker Disclosures

Dr. Robert DiDomenico, a speaker, is a consultant for PhaseBio Pharmaceuticals, Inc and received grant/research support from CSL Behring. Dr. Patrick Wieruszewski, a speaker, is a consultant for La Jolla Pharmaceutical Company. All of the relevant financial relationships listed for these individuals will be mitigated through peer review. All other speakers, planning committee members, and reviewers who contributed to this activity have no relevant financial relationships with ineligible companies to disclose.

Modified on May 30, 2023